About: Nathanael Gray

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Nathanael Gray Goto Sponge NotDistinct Permalink

An Entity of Type : wikidata:Q901, within Data Space : dbpedia.org associated with source document(s)
QRcode icon

http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FNathanael_Gray&graph=http%3A%2F%2Fdbpedia.org&graph=http%3A%2F%2Fdbpedia.org

Nathanael S. Gray is a Krishnan-Shah Family Professor of chemical and systems biology at Stanford University and director of cancer therapeutics programme at Stanford University School of Medicine. Previously he was a Nancy Lurie Marks Professor of biological chemistry and molecular pharmacology at Harvard Medical School and professor of cancer biology at Dana-Farber Cancer Institute. Gray is also co-founder, science advisory board member (SAB) and equity holder in C4 Therapeutics, Gatekeeper, Syros, Petra, B2S, Aduro, Jengu, Allorion, Inception Therapeutics, and Soltego (board member). C4 Therapeutics, which offered IPO in 2020, was founded based on the ground-breaking research of Jay Bradner, current president of Novartis Institutes for BioMedical Research (NIBR), and of Nathanael S. Gra

Attributes	Values
rdf:type	Thing foaf:Person person dul:NaturalPerson Eukaryote Person Human Animal animal eukaryote scientist species schema:Person Scientist
rdfs:label	Nathanael Gray (de) Nathanael Gray (en)
rdfs:comment	Nathanael S. Gray ist ein Biochemiker und Molekularbiologe an der Stanford University. (de) Nathanael S. Gray is a Krishnan-Shah Family Professor of chemical and systems biology at Stanford University and director of cancer therapeutics programme at Stanford University School of Medicine. Previously he was a Nancy Lurie Marks Professor of biological chemistry and molecular pharmacology at Harvard Medical School and professor of cancer biology at Dana-Farber Cancer Institute. Gray is also co-founder, science advisory board member (SAB) and equity holder in C4 Therapeutics, Gatekeeper, Syros, Petra, B2S, Aduro, Jengu, Allorion, Inception Therapeutics, and Soltego (board member). C4 Therapeutics, which offered IPO in 2020, was founded based on the ground-breaking research of Jay Bradner, current president of Novartis Institutes for BioMedical Research (NIBR), and of Nathanael S. Gra (en)
dcterms:subject	Living people Year of birth missing (living people) American chemists Harvard Medical School faculty University of California, Berkeley alumni
Wikipage page ID	52498321 (xsd:integer)
Wikipage revision ID	1089416297 (xsd:integer)
Link from a Wikipage to another Wikipage	Eli Lilly Award in Biological Chemistry Paul Marks Prize for Cancer Research Living people Year of birth missing (living people) Genomics Institute of the Novartis Research Foundation Stanford University Stanford University School of Medicine Stuart Schreiber Dana-Farber Cancer Institute Meyenburg Prize American chemists Harvard Medical School faculty University of California, Berkeley alumni Broad Institute UC Berkeley American Association for Cancer Research Harvard Medical School AACR Awards National Science Foundation dbr:Purvalanol dbr:BMK1 dbr:Torin1
sameAs	Nathanael Gray Nathanael Gray Nathanael Gray Nathanael Gray Nathanael Gray Nathanael Gray Nathanael Gray
workplaces	Harvard Medical School (en) Stanford University (en) (en) Dana-Farber Cancer Institute (en) Genomics Institute of the Novartis Research Foundation (en)
dbp:wikiPageUsesTemplate	dbt:Authority_control dbt:Reflist dbt:Infobox_scientist
alma mater	UC Berkeley (en) (en)
has abstract	Nathanael S. Gray ist ein Biochemiker und Molekularbiologe an der Stanford University. (de) Nathanael S. Gray is a Krishnan-Shah Family Professor of chemical and systems biology at Stanford University and director of cancer therapeutics programme at Stanford University School of Medicine. Previously he was a Nancy Lurie Marks Professor of biological chemistry and molecular pharmacology at Harvard Medical School and professor of cancer biology at Dana-Farber Cancer Institute. Gray is also co-founder, science advisory board member (SAB) and equity holder in C4 Therapeutics, Gatekeeper, Syros, Petra, B2S, Aduro, Jengu, Allorion, Inception Therapeutics, and Soltego (board member). C4 Therapeutics, which offered IPO in 2020, was founded based on the ground-breaking research of Jay Bradner, current president of Novartis Institutes for BioMedical Research (NIBR), and of Nathanael S. Gray, while he was professor at Harvard Medical School. Before moving to Stanford University, Nathanael S. Gray created Center for Protein Degradation at Harvard Medical School with $80 million agreement with Deerfield Management venture capital firm. In 2020, Gray Lab permanently moved to Stanford University, that was stated by Stuart Schreiber, co-founder of Broad Institute as "Stanford's huge gain". (en)
institution	Genomics Institute of the Novartis Research Foundation Stanford University Dana-Farber Cancer Institute Harvard Medical School
prov:wasDerivedFrom	wikipedia-en:Nathanael_Gray?oldid=1089416297&ns=0
page length (characters) of wiki page	5354 (xsd:nonNegativeInteger)
alma mater	UC Berkeley
foaf:isPrimaryTopicOf	wikipedia-en:Nathanael_Gray
is Link from a Wikipage to another Wikipage of	Eli Lilly Award in Biological Chemistry Peter G. Schultz Paul Marks Prize for Cancer Research Meyenburg Prize AACR Awards Nathanael Nathanael S. Gray
is Wikipage redirect of	Nathanael S. Gray
is Wikipage disambiguates of	Nathanael
is notable students of	Peter G. Schultz
is notable student of	Peter G. Schultz
is foaf:primaryTopic of	wikipedia-en:Nathanael_Gray

Faceted Search & Find service v1.17_git139 as of Feb 29 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 63 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software